TerrAscend
A Biopharmaceutical and Wellness Company creating and delivering quality products and services that meet the evolving needs of the Canadian cannabis market.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | $79.0m | Post IPO Debt | |
| Total Funding | 000k | ||
| CAD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 33 % | 18 % | 28 % | (3 %) | (14 %) | 5 % | 7 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 31 % | 16 % | 22 % | 20 % | 25 % | 26 % | 25 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 1 % | (133 %) | (30 %) | (26 %) | (10 %) | (12 %) | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Equity research estimates
Related Content
TerrAscend is a global company specializing in cannabis products, brands, and services. The company is dedicated to producing high-quality cannabis offerings, grounded in scientific research and innovation. TerrAscend operates in the burgeoning cannabis market, which includes medicinal and recreational cannabis products.
The company serves a diverse range of clients, including medical patients, recreational users, and other businesses within the cannabis industry. TerrAscend's business model is multifaceted, encompassing cultivation, processing, manufacturing, and retail. They grow cannabis plants, process them into various products, and sell these products through their own retail brands and other distribution channels.
TerrAscend generates revenue through the sale of cannabis products, which include dried flower, oils, edibles, and other infused products. They also offer ancillary products and services that support the cannabis industry. The company has expanded its footprint through strategic acquisitions, such as Arise Bioscience, The Apothecarium, State Flower, and Ilera Healthcare, which have been integrated into its operations to enhance growth and market presence.
The company is led by experienced professionals, including CEO and Executive Chairman Jason Ackerman, who has been instrumental in driving the company's growth strategy. TerrAscend is committed to maintaining high standards of quality and compliance, ensuring that their products meet rigorous safety and efficacy standards.
In summary, TerrAscend is a key player in the global cannabis market, offering a wide range of high-quality products and services, and is poised for continued growth through innovation and strategic expansion.
Keywords: cannabis, cultivation, processing, manufacturing, retail, medicinal, recreational, innovation, quality, acquisitions.
Tech stack
Investments by TerrAscend
Edit
